GlassScriptPhysician profile
Marc Schatz
NPI 1376004176
$44,829.04
in general payments reported to CMS, 2019-2025
13 companies · $13K in 2025
The $13K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,200 · 2022: $1,369 · 2023: $1,124 · 2024: $28K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $35K · Travel and Lodging: $3,676 · Food and Beverage: $3,585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $35,000.00 |
| Travel and Lodging | $3,675.65 |
| Food and Beverage | $3,584.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $21,598.97 | 2024-2025 | |
| Smith+Nephew, INC. | $15,000.00 | 2024-2025 | |
| Exactech, INC. | $3,472.44 | 2025 | |
| Stryker Corporation | $2,466.95 | 2022-2025 | Variax, Axsos, Alphavent |
| Alon Medical Technology | $1,200.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $461.53 | 2023-2024 | A.L.P.S., Dvr Anatomic Kickstand, Juggerknotless Soft Anchor |
| Flower Orthopedics Coporation | $133.77 | 2023 | |
| Si-Bone, INC. | $131.42 | 2022 | |
| Medtronic, INC. | $130.87 | 2024 | Aquamantys(Tm) |
| Linvatec Corporation | $107.69 | 2024 | Biobrace 23mm |
| Ermi LLC | $49.69 | 2025 | |
| Bioventus LLC | $47.92 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Skeletal Dynamics INC | $27.79 | 2024 | Implate, Align, Ijs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Schatz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.